CNS has worked with over 65 clients, mainly SMEs and several of the current top 10 Pharma and Biotech companies since 2003. Of this number over 50% are US companies, 30% Australian and 20% Europe/Asia. Furthermore, over 90% of our clients have worked with CNS on more than one study and on occasion throughout their product’s early phase development.
CNS is a full service CRO specialising in early stage clinical trials in Australia and New Zealand, a region that offers a fast and pragmatic regulatory pathway to the clinic and early stage trials. CNS is unique in Australia through offering a complete pathway from the preclinical planning and implementation right up to clinical proof of concept trials and beyond – all tailored specifically towards SME biotechs.
